Tezacaftor is a medication used for the treatment of cystic fibrosis. It is available in fixed-dose combination medications.
Tezacaftor is a medication used for the treatment of cystic fibrosis. It is available in fixed-dose combination medications.
The combination of tezacaftor with ivacaftor (brand name Symdeko) was approved for medical use in the United States in February 2018, and in Canada in June 2018. As brand name Symkevi it was approved for medical use in the European Union in October 2018.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).